These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 187621)

  • 21. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
    Short E; Morris RC; Sebastian A; Spencer M
    J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of parathyroid hormone and vitamin D in essential hypertension.
    Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of the parathyrin-related protein (PTH-RP) in the diagnosis of cancer-associated hypercalcemia].
    Sagarra E; Villabona C; Bonnin R; Moliner R; Merino FJ; Sahún M; Soler J
    Med Clin (Barc); 1995 Oct; 105(12):450-4. PubMed ID: 7490935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
    Rajala MM; Klee GG; Heath H
    J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders].
    Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immobilisation hypercalcemia.
    Evans RA; Bridgeman M; Hills E; Dunstan CR
    Miner Electrolyte Metab; 1984; 10(4):244-8. PubMed ID: 6087102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic tests in parathyroid diseases].
    Burckhardt P
    Schweiz Med Wochenschr; 1986 Feb; 116(6):173-8. PubMed ID: 3006236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of hypercalcemia.
    Endres DB
    Clin Biochem; 2012 Aug; 45(12):954-63. PubMed ID: 22569596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum ionized calcium, nephrogenous and total urinary cyclic AMP and urinary phosphate in normal subjects.
    Thode J; Holmegaard SN; Siggaard-Andersen O
    Scand J Clin Lab Invest; 1984 Apr; 44(2):111-8. PubMed ID: 6326252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
    Fox J; Heath H
    Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical studies using a highly sensitive radioimmunoassay for mid-region and carboxy terminus of parathyroid hormone in normal, hypo- and hypercalcemic states].
    Fukase M; Fujita T; Matsumoto T; Ogata E; Iijima T; Takezawa J; Saito K; Ishige H; Fujimoto M
    Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):807-27. PubMed ID: 2553507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic hypercalciuria: hydrochlorothiazide decrease urinary calcium without altered renal response to parathyroid hormone.
    Van Den Berg CJ; Tucker RM; Dousa TP
    J Clin Endocrinol Metab; 1982 Jul; 55(1):23-6. PubMed ID: 6281301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.
    Stewart AF; Horst R; Deftos LJ; Cadman EC; Lang R; Broadus AE
    N Engl J Med; 1980 Dec; 303(24):1377-83. PubMed ID: 6253785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary cAMP excretion during surgery: an index of successful parathyroidectomy in patients with primary hyperparathyroidism.
    Spiegel AM; Marx SJ; Brennan MF; Brown EM; Koehler JO; Aurbach GD
    J Clin Endocrinol Metab; 1978 Sep; 47(3):537-42. PubMed ID: 233674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary cyclic AMP:creatinine ratio and nephrogenous cyclic AMP as indicators parathyroid functional status.
    Stuart CA; Prochnow PA
    Endocr Res; 1986; 12(1):49-67. PubMed ID: 3009173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].
    Quesada Gómez JM
    Endocrinol Nutr; 2009 Apr; 56 Suppl 1():14-9. PubMed ID: 19627756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate.
    Murad F; Pak CY
    N Engl J Med; 1972 Jun; 286(26):1382-7. PubMed ID: 4337769
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia.
    Dohan PH; Yamashita K; Larsen PR; Davis B; Deftos L; Field JB
    J Clin Endocrinol Metab; 1972 Dec; 35(6):775-84. PubMed ID: 4343935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.